Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data Shares Move to Nasdaq National Market

NEW YORK, Dec. 19 (GenomeWeb News) - Nasdaq moved Clinical Data's exchange listing from the Capital Market to the National Market, Clinical Data said today.


Clinical Data's shares began trading on the Nasdaq National Market this morning. The company's stock symbol, CLDA, remains the same.


The Nasdaq Capital Market was formerly known as the Nasdaq Small Cap Market.


According to Israel Stein, Clinical Data's president and CEO, the move will "build shareholder value" as the company continues to integrate Genaissance Pharmaceuticals and Icoria.


The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.